Report - Investor Presentation - content.equisolve.net · Robust Development Pipeline 6 Program Discovery Preclinical Phase 1 Phase 2a Phase 2b Phase 3 Hepatitis C (HCV) CC-31244 – University

Please pass captcha verification before submit form